Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
about
Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancerMonoclonal antibodies in lung cancer.Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.Association of TNFα-308, IFNγ+874, and IL10-1082 gene polymorphisms and the risk of non-small cell lung cancer in the population of the South Indian state of Telangana.
P2860
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@en
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@nl
type
label
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@en
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@nl
prefLabel
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@en
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@nl
P2093
P356
P1476
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.
@en
P2093
Efnan Olcay
Godefridus J Peters
Lale Erdem
Leticia G Leon
P304
P356
10.2741/3679
P577
2011-01-01T00:00:00Z